Mode
Text Size
Log in / Sign up
N/A N=109 Randomized Single-blind Treatment

Weight Loss Treatment for Veterans With Binge Eating

Binge Eating Disorder

Enrolled (actual)
109
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Change in Eating Disorder Examination-Self-report Questionnaire (EDE-Q) — 3.18; 2.89; 2.81; 2.13 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
MOVE! (Behavioral); MOVE!+CBT (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
May 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Eating Disorder Examination-Self-report Questionnaire (EDE-Q)
3.18; 2.89; 2.81; 2.13; 2.57; 2.00
PRIMARY
Change in Binge Episodes From Eating Disorder Examination Interview
21.23; 21.75; 7.02; 3.64; 6.02; 5.38
SECONDARY
Change in Patient Health Questionnaire-9 (PHQ-9)
9.44; 8.41; 7.89; 5.38; 7.95; 6.92
SECONDARY
Change in PTSD Checklist (PCL-5)
37.48; 31.27; 27.67; 22.62; 29.29; 28.46
SECONDARY
Weight and Eating Quality of Life (WE-QoL)
1.58; 1.50; 1.29; 1.12; 1.33; 1.05
SECONDARY
Change in European Quality of Life (EuroQoL-5D)
56.8; 52.8; 63; 69.05; 66.35; 68.07
SECONDARY
Night Eating Questionnaire (NEQ)
21.06; 21.25; 18.89; 15.70; 17.89; 16.98
SECONDARY
CBT Session Attendance (Treatment Dose)
7.75

Summary

This study aims to adapt and test a cognitive behavioral therapy (CBT) treatment that can be administered concurrently with the Veteran's Health Administration (VHA) MOVE! weight management program for Veterans with DSM-5 Binge Eating Disorder (BED) and high weight.

Eligibility Criteria

Inclusion Criteria

  • BMI>=25
  • Presence of recurrent binge eating on the MOVE! Survey

Exclusion Criteria

  • More than 4 MOVE! sessions in the prior year
  • Active psychosis or suicidal ideation
  • Medical or psychiatric illness, or cognitive deficits that interfere with providing consent or completing assessments
  • Pregnancy or lactation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03234881). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search